Why is Jenburkt Pharma falling/rising?

As of 07-Nov, Jenburkt Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 1,202.80, which reflects a decrease of 13.95 points or 1.15%. The stock has been underperforming recently, having fallen for three consecutive days, resulting in a total decline of 5.73% during this period. Today's trading saw the stock reach an intraday low of Rs 1170.1, indicating a significant drop of 3.83%. Additionally, the stock's delivery volume has decreased dramatically, falling by 79.54% compared to the 5-day average, suggesting a lack of investor interest. Over the past week, the stock has underperformed the sector by 0.81%, and its year-to-date performance shows a slight decline of 0.98%.
In the broader market context, Jenburkt Pharmaceuticals' recent performance contrasts with the Sensex, which has shown a modest increase of 6.50% year-to-date. Over the past week, while the stock has decreased by 5.51%, the benchmark index has only fallen by 0.86%, highlighting the stock's relative weakness. Despite a strong performance over longer periods, such as a 105.40% increase over three years, the current trend indicates a troubling short-term outlook for the company, compounded by falling investor participation and liquidity concerns.